Company intelligence / Profile preview

Vionix Biosciences

New Delhi, Delhi, Indiavionix.bio ↗

Ownership: Private
Development stage: Preclinical

Overview

Vionix Biosciences is developing a novel portable desktop diagnostic system that uses advanced spectroscopy and artificial intelligence to enable rapid, affordable, and continuous medical diagnostics. The company aims to revolutionize early disease detection—including cancer—by making frequent at-home or point-of-care testing possible using non-invasive samples such as breath, urine, or blood. No clinical trial results are publicly available as of June 2025.

Therapeutic areas: OncologyOther
Modalities: DeviceArtificial intelligence-based diagnosticsSpectroscopic technology platform
Industry: Metabolite Diagnostics

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of June 2025.

Beyond the preview

Go deeper on Vionix Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vionix Biosciences.

Explore the full profile